Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
Download
Download
DownloadPreview
s13023-021-01758-9.pdf
- Published Version
(1MB)
| Preview
Available under license: Creative Commons Attribution
Export
Kourakis, S, Timpani, Cara 
ORCID: 0000-0003-4567-4319, Campelj, Dean G, Hafner, P, Gueven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036
(2021)
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
Orphanet Journal of Rare Diseases, 16 (1).
ISSN 1750-1172
(In Press)
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/42092 |
| DOI | 10.1186/s13023-021-01758-9 |
| Official URL | https://ojrd.biomedcentral.com/articles/10.1186/s1... |
| Subjects | Historical > FOR Classification > 0601 Biochemistry and Cell Biology Historical > FOR Classification > 1116 Medical Physiology Current > Division/Research > Institute for Health and Sport |
| Keywords | pharmacological corticosteroid therapy, Duchenne Muscular Dystrophy, mutations, dystrophin gene, truncated dystrophin protein |
| Citations in Scopus | 20 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)